Notably, in hepatocellular carcinoma, ACSS2 has a negative relationship with HCC malignancy, decreased expression of ACSS2 not only promotes invasion and migration ability of HCC cells, but also promotes EMT (Sun et al., 2017). This evidence concerns the gene ACSS2 and hepatocellular carcinoma.